Location History:
- Poway, CA (US) (2021)
- Millbrae, CA (US) (2021)
Company Filing History:
Years Active: 2021
Title: Kristen Baltgalvis: Innovator in Therapeutic Antibodies
Introduction
Kristen Baltgalvis is a prominent inventor based in Poway, California, known for her significant contributions to the field of therapeutic antibodies. With a total of two patents to her name, she has made strides in developing innovative solutions for medical challenges.
Latest Patents
Her latest patents include a method of using a bispecific antibody to conditionally inhibit a receptor signaling complex. This invention describes the design of bispecific antibodies that function as conditionally effective therapeutics by binding to a functionally silent epitope on one component of a targeted signaling complex. Simultaneously, these antibodies bind to a second protein, whose expression or accessibility is cell- or disease environment-specific. This proximity leads to an alteration of signal transduction. Another notable patent is the ACVR2A-specific antibody and method of treatment of muscle atrophy. This disclosure provides antibodies that specifically bind to and block signaling by ACVR2A, while not affecting ACVR2B. These antibodies may be used for treating various conditions associated with muscle atrophy.
Career Highlights
Throughout her career, Kristen has worked with notable companies such as Torch Therapeutics and Rigel Pharmaceuticals, Incorporated. Her work in these organizations has allowed her to further her research and development in the field of therapeutic antibodies.
Collaborations
Kristen has collaborated with esteemed colleagues, including Todd M Kinsella and Ramesh Bhatt, contributing to her innovative projects and research endeavors.
Conclusion
Kristen Baltgalvis stands out as a leading inventor in the field of therapeutic antibodies, with her patents paving the way for advancements in medical treatments. Her work continues to impact the scientific community and improve patient outcomes.